124 related articles for article (PubMed ID: 33172934)
21. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
22. Gene silencing in vitro and in vivo using intronic microRNAs.
Lin SL; Ying SY
Methods Mol Biol; 2006; 342():295-312. PubMed ID: 16957384
[TBL] [Abstract][Full Text] [Related]
23. Gene silencing in vitro and in vivo using intronic microRNAs.
Lin SL; Ying SY
Methods Mol Biol; 2013; 936():209-29. PubMed ID: 23007511
[TBL] [Abstract][Full Text] [Related]
24. The long noncoding RNA
Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis.
Jin S; He J; Zhou Y; Wu D; Li J; Gao W
J Cell Mol Med; 2020 Apr; 24(8):4839-4849. PubMed ID: 32176463
[TBL] [Abstract][Full Text] [Related]
26. Alternative polyadenylation allows differential negative feedback of human miRNA miR-579 on its host gene ZFR.
Hinske LC; Galante PA; Limbeck E; Möhnle P; Parmigiani RB; Ohno-Machado L; Camargo AA; Kreth S
PLoS One; 2015; 10(3):e0121507. PubMed ID: 25799583
[TBL] [Abstract][Full Text] [Related]
27. A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
Kwok ZH; Roche V; Chew XH; Fadieieva A; Tay Y
Int J Cancer; 2018 Aug; 143(3):668-678. PubMed ID: 29574704
[TBL] [Abstract][Full Text] [Related]
28. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
[TBL] [Abstract][Full Text] [Related]
30. Stable Intronic Sequence RNAs (sisRNAs): An Expanding Universe.
Chan SN; Pek JW
Trends Biochem Sci; 2019 Mar; 44(3):258-272. PubMed ID: 30391089
[TBL] [Abstract][Full Text] [Related]
31. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
[TBL] [Abstract][Full Text] [Related]
32. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
Qu R; Hao S; Jin X; Shi G; Yu Q; Tong X; Guo D
Gene; 2018 Feb; 642():354-361. PubMed ID: 29128635
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
35. Intronic microRNA: discovery and biological implications.
Li SC; Tang P; Lin WC
DNA Cell Biol; 2007 Apr; 26(4):195-207. PubMed ID: 17465886
[TBL] [Abstract][Full Text] [Related]
36. Intron-mediated RNA interference, intronic microRNAs, and applications.
Ying SY; Chang CP; Lin SL
Methods Mol Biol; 2010; 629():205-37. PubMed ID: 20387152
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.
Wang J; Du Y; Liu X; Cho WC; Yang Y
Biomed Res Int; 2015; 2015():823620. PubMed ID: 26064956
[TBL] [Abstract][Full Text] [Related]
40. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
